Skip to main content
John Belperio, MD, Pulmonology, Los Angeles, CA, Ronald Reagan UCLA Medical Center

JohnABelperioMD

Pulmonology Los Angeles, CA

Critical Care Medicine, Pleural Disease

Professor, Medicine, UCLA School of Medicine

Dr. Belperio is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Belperio's full profile

Already have an account?

  • Office

    UCLA Medical Center
    200 Medical Plaza, Suite 365-B
    Los Angeles, CA 90095
    Phone+1 310-825-8061
    Fax+1 310-825-8061
  • Is this information wrong?

Education & Training

  • University of Michigan Health System
    University of Michigan Health SystemFellowship, Pulmonary Disease and Critical Care Medicine, 1997 - 2000
  • University of Maryland
    University of MarylandResidency, Internal Medicine, 1994 - 1997
  • Lewis Katz School of Medicine at Temple University
    Lewis Katz School of Medicine at Temple UniversityClass of 1994

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2000 - 2025
  • MI State Medical License
    MI State Medical License 1997 - 2000

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • Super Doctor SuperDoctors.com

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Theravance Biopharma : Announces Top-Line Results from Phase 2 Study of Nezulcitinib in Patients Hospitalized with Acute Lung Injury Due to COVID-19 (Form 8-K)
    Theravance Biopharma : Announces Top-Line Results from Phase 2 Study of Nezulcitinib in Patients Hospitalized with Acute Lung Injury Due to COVID-19 (Form 8-K)June 21st, 2021
  • UCLA Launches Fundraising Effort for New Research Center for Sarcoidosis, Other Advanced Lung Diseases
    UCLA Launches Fundraising Effort for New Research Center for Sarcoidosis, Other Advanced Lung DiseasesNovember 18th, 2019
  • $20 Million Fundraising Effort Will Support Efforts to Improve Treatment for Lung Disease
    $20 Million Fundraising Effort Will Support Efforts to Improve Treatment for Lung DiseaseNovember 14th, 2019
  • Join now to see all

Grant Support

  • The Role Of Chemokines During Lung Allograft DysfunctionNational Heart, Lung, And Blood Institute2005–2009
  • Chemokine Biology In Bronchiolitis Obliterans SyndromeNational Heart, Lung, And Blood Institute2001–2005

Hospital Affiliations